Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FORRESTANIA RESOURCES LIMITED Director's Dealing 2026

Jan 8, 2026

64945_rns_2026-01-08_8ae3c000-4f0f-4b96-997a-2b6eef12b241.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Forrestania Resources Ltd

ABN 41 647 899 698

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director David Geraghty

Date of last notice 2 January 2026

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest (1) Indirect(2) Indirect(3) Direct
Nature of indirect interest(includingregisteredholder)Note: Provide details of the circumstancesgiving rise to the relevant interest. (1) Mandarin Rock Pty Ltd (director and shareholder)(2) Roologic Pty Ltd is a company controlled by thedirector’s spouse.(3) NA
Date of change 6 & 9 January 2026
No. of securities held priorto change (1.1)30,000,000 Fully Paid Ordinary Shares (FPO)(1.2)16,750,000 Performance Rights (PR)(2.1) 3,000,000 FPO(2.2) 2,486,958 Listed options ex. at $0.15 on or before30/06/2026 (FRSOA)(3) 150,000 FPO
Class (1.1)FPO(1.2)PR(2.1) FPO(2.2) FRSOA(3) FPO

2 January 2026

  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number acquired (1.1)2,375,000(2.2)(A) 259,000
Number disposed (1.2)2,375,000(2.2)(B) 2,745,958
Value/ConsiderationNote: If consideration is non-cash, providedetails and estimated valuation (1.1 & 1.2) Nil. The vesting conditions for Tranches 2 and 7of Performance Rights, approved by shareholders, has beensatisfied.(2.2)(A) $41,400(2.2)(B) $411,893.70
No. of securities held afterchange (1.1)34,250,000 FPO(1.2)12,500,000 PR(2.1) 5,745,958 FPO(3) 150,000 FPO
Nature of changeExample:on-markettrade,off-markettrade,exerciseofoptions,issueofsecurities under dividend reinvestmentplan, participation in buy-back (1.1 & 1.2) Issue of securities following vesting of Tranches2 and 7 of Performance Rights, approved by shareholders.(2.2)(A) On-market purchase of FRSOA(2.2)(B) Exercise of FRSOA

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed No
above traded during a+closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the NA
trade to proceed during this period?
If prior written clearance was provided, on what date was NA
this provided?
  • See chapter 19 for defined terms.

2 January 2026

01/01/2011

Appendix 3Y Page 3